Great Lakes Advisors, LLC Pacira Bio Sciences, Inc. Transaction History
Great Lakes Advisors, LLC
- $10.8 Billion
- Q4 2024
A detailed history of Great Lakes Advisors, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 236,552 shares of PCRX stock, worth $5.51 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
236,552
Previous 470,092
49.68%
Holding current value
$5.51 Million
Previous $7.08 Million
37.05%
% of portfolio
0.04%
Previous 0.06%
Shares
15 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$187 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$123 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$76.1 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$52.6 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$46.4 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.07B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...